As the number of people over the age of 65 years increases, so will the number of people with age-related neurological conditions, such as dementia. It is predicted that by 2040, this figure will rise to over one and a half million people in the UK (Arvanitakis et al, 2019). In clinical practice, before the dementia strategy was launched, it was not uncommon to see a case presented to a ‘fast track’ continuing healthcare funding panel, an urgent funding request for end-of-life care, of a person in the advanced stages of an undiagnosed dementia. This meant that their needs for care and support, as well as those of their family members, had been unrecognised and unmet throughout their condition. Timely diagnosis of dementia can lead to several benefits, including access to a pathway of care and a network of services.